Stephanie Dudzinski MD, PhD

Over the moon that @sumeethj and I have matched at @MDAndersonNews and @BCMNeurosurgery for #radonc and #neurosurgery! We can't wait to start this new chapter of our lives with our family and incredible co-residents! #HoustonBound #Match2021

📢 New AJCC9V staging for HPV+ oropharyngeal cancer improves prognostic accuracy vs AJCC8E. ✅ Incorporates ENE ✅ Refines nodal groupings ✅ Validated in 14K+ surgical cases #HeadandNeckCancer #HPV #oncology bit.ly/4mh0wr2

The semi-annual meetings are always a strong call to action for all who serve @NRGonc 💪🏼 For those curious about all things membership and how to get involved, our episode with @dsmgyo was both hilarious and illuminating: 🎧 tinyurl.com/23eywwyw 🍎 tinyurl.com/hxsc8sy4…

Good trials beget good trials! RTOG 1112 ➡️ GI012 (HELIO-RT) ☢️ @ldawsonmd Dr. Jennifer Wo @MassGenBrigham Let’s keep our seats at the HCC table & enroll our pts: BCLC Class C w/ MVI! @NRGonc @RTOGFoundation

My 📱knows me too well that RT + immunology trials get me excited….so it made the cover slide 🌈 (couldn’t fix it…) 🤞🏻for synergy (without too much toxicity…) between IO + ☢️ @AnkerUVMRadOnc @NRGonc @RTOGFoundation @MassGenBrigham Dr. Aparna Parikh

Most viewed this week from @JAMAOnc: Total neoadjuvant therapy (TNT) for stage II/III rectal cancer, despite variations in regimen choice, showed efficacy outcomes in routine clinical practice consistent with clinical trials. ja.ma/4o8lN7R

BREAKING: We uncovered a potent immune alliance that could change how we treat solid tumors. Published in @Cancer_Cell , we show that Th17 cells *must* work with B cells to eliminate tumors—and keep it from coming back. 📄 cell.com/cancer-cell/fu… 🧵1/12👇Let’s walk through it:

Yay! JANUS enrollment complete! 💪👏 @hitchcock_kate Personally excited for this one as I helped enroll & contour 2 cases for this trial @DrEmmaHolliday 💻🖍️ Can’t wait to see the results for this Watch & Wait trial w/ doublet vs. triplet chemo! ☢️👀 @NRGonc @RTOGFoundation

I’m honored to share that I’ve been invited to moderate a series of ASTRO webinars focused on radiotherapy for benign conditions this October, following the ASTRO Annual Meeting. As we plan the content, I’d love to hear from colleagues and the wider Radonc community: •Which…

🙏🏻 to @RTOGFoundation for the opportunity to serve as a Communications intern! This experience taught me: -Clinical trial design considerations ☢️ -Collab skills w/ multi-d colleagues 🤝 -Methods to support trial enrollment Hopeful for more @NRGonc involvement in my future 🤞🏻

Congratulations to our 2025-2026 RTOG Foundation Communications Interns! We are very thankful to have you as part of our team. Stay tuned for our fall quarterly newsletter to learn more about Drs. Lee and Narvaez-Rojas. @axnarvaezMD @djlee714

NOW LIVE! Just announced at #NRG2025: We interview Immediate Past Chair of the Lung Cancer Committee @JeffBradleyMD to discuss #LungCancer in NRG and the importance of mentoring the next generation of researchers: NRGOncology.org/Podcasts @StephenChunMD @lauren_henke

Great to be in DC today @NRGonc giving an update on the progress of #HN014 #C-PRE for patients with advanced, resectable #skin #CSCC cancer. >100 sites activated in the US alone and accrual 🚀@NCICancerCtrl @TROGfightcancer @CDNCancerTrials @Regeneron #OncSurgery @MDAndersonNews

GU013: HIGH-FIVE 👋✋ Important trial for our pts w/ high-risk prostate cancer testing if convenient SBRT controls distant mets as well as conventional/moderate frac ☢️ @KHoffmanMD @MDAndersonNews Accrual is off to a great start! Let’s keep it going 💪 @NRGonc @RTOGFoundation

Very happy 🤗 start to the last day of Summer @NRGonc 2025 seeing excellent accrual for GU009 (PREDICT-RT) @DrPaulNguyen @sartor_oliver & GU010 (GUIDANCE) @ndesai2005 @aleberlin2 👏💪 Trial enrollment ➡️ answer important clinical ❓➡️better patient care! @RTOGFoundation

Newest @NRGonc Podcast w @JeffBradleyMD on 15 years as Lung Core Chair. Thanks Jeff for all you've done in lung cancer! #nrg2025 open.spotify.com/episode/2HsQaY… @lauren_henke @RTOGFoundation @PennRadOnc @PennCancer @theNCI @NIH @KHigginsMD

Currently there are 32 trials in NRG that include PROs. #NRG2025

Abstract submission is open for #ACRO2026 ⬇️⬇️⬇️ Great opportunity for #radonc trainees to get showcase your work!

New NRG Podcast episode 🚨

Never a day off for our NRG Podcast team - We're rolling on-site at the #NRG2025 meeting filming on our Veteran Affairs/MTF Subcommittee and VA research priorities for a future episode. NRGOncology.org/Podcast @StephenChunMD @lauren_henke @Baylor

Check out this new case on eContour! 🧠 Big thanks to @MeganEOrr! And congrats! 🎉